Celaleddin SOYALP, Ahmet Ufuk KÖMÜROĞLU, Nureddin YÜZKAT, Yıldıray BAŞBUGAN, Yunus Emre TUNÇDEMİR

Effects of Sedation Doses of Propofol and Midazolam on Levels of NGAL, Cystatin-C, KIM-1 in Rats

Limited data are available regarding the impact of their sedation doses midazolam and propofol on early biomarkers of acute kidney injury (AKI). This study aimed to investigate the effects of sedation doses propofol and midazolam on early biomarkers such as neutrophil gelatinase-associated lipocalin (NGAL), cystatin C (CyC) and kidney injury molecule 1 (KIM-1) of AKI. A total of 24 Wistar albino rats were separated into three groups (n = 8 per group): a control group (intraperitoneal injection [IP] saline injection once daily for 7 days), a propofol group (IP injection of 2.5 mg/kg propofol once daily for 7 days), and a midazolam group (IP injection of 5 mg/kg midazolam once daily for 7 days). For each group, urinalysis (for urea, creatinine, total protein, NGAL, CyC, and KIM-1) was performed on Day 0 and Day 7; serum analysis (for urea, creatinine, total protein, albumin globulin, ALT, AST, NGAL, CyC, and KIM-1) was performed on day 7. No significant difference was noted between control, propofol and midazolam groups in terms of Day 7 serum KIM-1, CyC, and NGAL levels and Day 0 and Day 7 urinalysis findings (KIM-1, CyC, NGAL, urea, and creatinine levels). DISCUSSION AND CONCLUSION: The findings revealed a similar safety profile for seven-day propofol and midazolam administration in rats in terms of the traditional (creatinine, urea) and early biomarkers (NGAL, CyC, KIM-1) of AKI

PDF

___

1. Jacobi GL, Fraser DB, Coursin DB, et al. Task Force of the American College of Critical Care Medicine (ACCM) of the Society of Critical Care Medicine (SCCM), American Society of Health System Pharmacists (ASHP), American College of Chest Physicians. Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult. Crit Care Med 2002; 30: 119- 141.
2. Van CP, van DS, Loef BG, et al. Discomfort and factual recollection in intensive care unit patients. Crit Care. 2004; 8: R467-73.
3. Lonardo NW, Mone RN, Kimball EJ, et al, Propofol is associated with favorable outcomes compared with benzodiazepines in ventilated intensive care unit patients. Am J Respir Crit Care Med 2014; 189: 1383-194.
4. Payen J, Chanques G, Mantz J, Hercule C, et al Current practices in sedation and analgesia for mechanically ventilated critically ill patients: a prospective multicenter patient-based study. Anesthesiology 2007; 106: 687-695.
5. Zhou Y, Jin X, Kang Y, et al. Midazolam and propofol used alone or sequentially for long-term sedation in critically ill, mechanically ventilated patients: a prospective, randomized study. Crit Care 2014; 18: 122.
6. Singbartl K. and Kellum J.A. AKI in the ICU: Definition, epidemiology, risk stratification, and outcomes. Kidney Int 2012; 81: 819-825.
7. Hoste EA, Clermont G, Kersten A, et al. RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: A cohort analysis. Crit Care 2006; 10: R73.
8. Bagshaw S.M, George C and Bellomo R.. ANZICS Database Management Committe. A comparison of the RIFLE and AKIN criteria for acute kidney injury in critically ill patients. Nephrol Dial Transplant 2008;23: 1569-1574.
9. Bellomo RC, Ronco JA, Kellum RL, Mehta and Palevsky. Acute renal failure definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004; 8: 204-12. DOI: 10.1186/cc2872
10. Leite TT, Macedo E, Martins S, Neves FM and Libório AB. Renal Outcomes in Critically Ill Patients Receiving Propofol or Midazolam. Clin J Am Soc Nephrol 2015; 10: 1937-1945.
11. Moore E, Bellomo R and Nichol A. Biomarkers of acute kidney injury in anesthesia, intensive care and major surgery: from the bench to clinical research to clinical practice. Minerva Anestesiol 2010; 76: 425-440.
12. Ricci Z, Cruz D and Ronco C. The RIFLE criteria and mortality in acute kidney injury: A systematic review. Kidney Int 2008; 73: 538-546.
13. Schmidt-Ott KM. Mori K, Kalandadze A, et al. Neutrophil gelatinase-associated lipocalin mediated iron traffic in kidney epithelia. Curr Opin Nephrol Hypertens 2006; 15: 442-449.
14. Haase-Fielitz AR, Bellomo P, Devarajan D, et al. Novel and conventional serum biomarkers predicting acute kidney injury in adult cardiac surgery-a prospective cohort study. Crit Care Med 2009; 37: 553-560.
15. Portilla DC, Dent T, Sugaya KK, et al. Liver fatty acid-binding protein as a biomarker of acute kidney injury after cardiac surgery. Kidney Int 2008; 73: 465-472.
16. Bennett M, Dent CL, Ma Q, et al. Urine NGAL predicts severity of acute kidney injury after cardiac surgery: a prospective study. Clin J Am Soc Nephrol 2008; 3: 665-73.
17. Dent C, Ma Q, Dastrala S, Bennett M, et al. Plasma neutrophil gelatinase-associated lipocalin predicts acute kidney injury, morbidity and mortality after pediatric cardiac surgery: a prospective uncontrolled cohort study. Crit Care 2007; 11:127.
18. Koyner JL, Bennett MR, Worcester EM, et al. Urinary cystatin C as an early biomarker of acute kidney injury following adult cardiothoracic surgery. Kidney Int 2008; 74: 1059-1069.
19. Royakkers AA, Van Suijlen JD, Hofstra LS, et al. Serum cystatin C-A useful endogenous marker of renal function in intensive care unit patients at risk for or with acute renal failure? Curr Med Chem 2007; 14: 2314-2317.
20. Han WK, Bailly V, Abichandani R, Thadhani R and Bonventre JV. Kidney Injury Molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury. Kidney Int. 2002; 62: 237- 244.
21. Hall RI, Sandham D, Cardinal P, et al. Study Investigators. Propofol vs midazolam for ICU sedation, a Canadian multicenter randomized trial. Chest 2001; 119: 1151-1159.
22. Vaja R, Mc L, Nicol and Sisley I. Anaesthesia for patients with liver disease. CEACCP 2009; 10: 15- 19.
23. Thuluvath PJ. Toward safer sedation in patients with cirrhosis: have we done enough? Gastrointest Endosc 2009; 70: 269-271.
24. Riphaus A, Wehrmann T, Weber B, et al. [S3- guidelines--sedation in gastrointestinal endoscopy]. Z Gastroenterol 2008; 46: 1298-1330.
25. Watanabe K, Hikichi T, Takagi T, et al. Propofol is a more effective and safer sedative agent than midazolam in endoscopic injection sclerotherapy for esophageal varices in patients with liver cirrhosis: a randomized controlled trial. Fukushima J Med Sci 2008; 64: 133-141.
26. Yang S, Chou WP and Pei L. Effects of propofol on renal ischemia/reperfusion injury in rats. Exp Ther Med 2013; 6: 1177-1183.
27. Hsing CH, Chou W, Wang JJ, Chen HW and Yeh CH. Propofol increases bone morphogenetic protein-7 and decreases oxidative stress in sepsis induced acute kidney injury. Nephrol Dial Transplant 2011; 26: 1162-1172.
28. Yoo YC, Shim JH, Song Y, Yang SYand Kwak YL. Anesthetics influence the incidence of acute kidney injury following valvular heart surgery. Kidney Int 2014; 86: 414-422.
29. Bang JY, Lee J, Oh J, Song J.G and Hwang GS. The influence of propofol and sevoflurane on acute kidney injury after colorectal surgery: a retrospective cohort study. Anesth Analg 2016; 123: 363-370.
30. Ammar AS and Mahmoud KM. Comparative effect of propofol versus sevoflurane on renal ischemia/reperfusion injury after elective open abdominal aortic aneurysm repair. Saudi J Anaesth 2016; 10: 301-307.
31. Story DA, Poustie S, Liu G and Mc Nicol PL. Changes in plasma creatinine concentration after cardiac anesthesia with isoflurane, propofol, or sevoflurane: A randomized clinical trial. Anesthesiology 2001; 95: 842-848.
32. Saricaoğlu F. Akinci SB, Oç B, et al. The effect of halothane, isoflurane, sevoflurane and propofol infusion on renal function after coronary artery bypass surgery. Middle East J Anaesthesiol 2006; 18: 955-964.
33. Song JC, Zhang MZ, Wu QC et al. Sevoflurane has no adverse effects on renal function in cirrhotic patients: A comparison with propofol. Acta Anaesthesiol Scand 2013; 57: 896-902.
34. Zhang Z, Chen K, Ni XZ and Fan H Sedation of mechanically ventilated adults in intensive care unit: a network meta-analysis. Sci Rep 2017; 7: 44979.
35. BarrientosVR, Mar Sánchez SM, Morales GC, et al. Prolonged sedation of critically ill patients with midazolam or propofol: impact on weaning and costs. Crit Care Med 1997; 2: 33-40.
36. Wadhwa V, Issa S, Garg R, et al. Similar risk of cardiopulmonary adverse events between propofol and traditional anesthesia for gastrointestinal endoscopy: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 2017; 15: 194-206.
37. Akbulut UE, Kartal S, Dogan U, et al.Propofol with and without midazolam for diagnostic upper gastrointestinal endoscopies in children. Pediatr Gastroenterol Hepatol Nutr 2019; 22: 217-224. DOI: 10.5223/pghn.2019.22.3.217.
38. Soleimanpour H, Safari S, Rahmani F, Jafari RA and Alavian SM. 2Intravenous hypnotic regimens in patients with liver disease; a review article. Anesth Pain Med 2015; 5: e23923.